Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessPancreatic adenocarcinoma third line systemic treatments: a retrospective cohort study
Chemotherapy for metastatic pancreatic adenocarcinoma (PDAC) primarily relies on FOLFIRINOX (LV5FU- irinotecan – Oxaliplatine) and Gemcitabine – Nab-Paclitaxel in the first-line setting. However, second-lines ...
-
Article
Open AccessSmall bowel adenocarcinoma phenoty**, a clinicobiological prognostic study
Small bowel adenocarcinoma (SBA) is a rare tumour with a poor prognosis. Molecular biology data on SBA carcinogenesis are lacking.
-
Article
Open AccessTumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II–III colorectal cancer
The aim of our study was to evaluate the prognostic role of immunological microenvironnement in stage II–III CRC patients.